Skip to main content
. 2013 Jun 24;8(6):e66123. doi: 10.1371/journal.pone.0066123

Table 1. Baseline characteristics of the included patients.

Characteristic Total (N = 83) ILMA* (n = 26) ILMA+ non-silver dressing (n = 26) ILMA+ silver dressing (n = 31)
Age (mean ± SD†) years 28.81 (14.45) 32.88 (12.92) 30.31 (15.41) 24.13 (13.97)
Duration of lesions (mean ± SD) weeks 7.95 (2.67) 8.31 (2.86) 8.46 (2.15) 7.23 (2.82)
Number of lesions (mean ± SD) 1.90 (1.21) 1.77 (1.34) 2.00 (1.47) 1.94 (1.12)
Male (%) 39 (47.0) 8 (30.8) 11 (42.3) 20 (64.5)
*

ILMA  =  intralesioinal meglumine antimoniate. †Standard deviation.